Effect of levofloxacin treatment on semen hyperviscosity in chronic bacterial prostatitis patients

L. O. Vicari, R. Castiglione, M. Salemi, B. O. Vicari, M. C. Mazzarino, E. Vicari

Research output: Contribution to journalArticle

Abstract

Changes in seminal fluid viscosity (SFV), reactive oxygen species (ROS) production, cytokines and seminal leucocyte concentration related to microbiological outcome in patients with chronic bacterial prostatitis (CBP) were studied. One hundred and ten infertile patients with CBP (positive sperm culture ≥105 colony-forming units [CFU] ml-1, pathogens or Chlamydia in expressed prostatic secretions) were treated with levofloxacin 500 mg daily for 14 consecutive days per month for 3 months. In case of bacterial prostatitis, two conditions were examined: responders, eradication of 0 to 3 CFU ml-1 (n = 78) and poor responders, >103 to 5 CFU ml-1 (n = 32). Compared with poor responders, responders showed a significant increase of sperm progressive motility and a significant decrease in seminal leucocyte count, SFV, liquefaction time, ROS production (in all fractions and conditions), seminal tumour necrosis factor-α and interleukin 6. None of these variables showed significant differences compared with a control group of 37 fertile men. On the other hand, the poor responders showed significant changes in these variables compared with matched pretreatment values. In patients with CBP, antibiotic therapy alone leads to eradication in ≈71%, with improvement of sperm progressive motility, SFV and the framework of prooxidative factors. However, in the remaining ≈29% with poor antibiotic responsiveness, a deterioration of all variables is observed.

Original languageEnglish
JournalAndrologia
DOIs
Publication statusAccepted/In press - 2015

Fingerprint

Prostatitis
Levofloxacin
Semen
Viscosity
Stem Cells
Sperm Motility
Reactive Oxygen Species
Anti-Bacterial Agents
Chlamydia
Therapeutics
Leukocyte Count
Spermatozoa
Interleukin-6
Leukocytes
Tumor Necrosis Factor-alpha
Cytokines
Control Groups

Keywords

  • Chronic bacterial prostatitis
  • Levofloxacin
  • Male infertility
  • Reactive oxygen species
  • Semen cytokines
  • Semen quantitative hyperviscosity

ASJC Scopus subject areas

  • Urology
  • Endocrinology

Cite this

Vicari, L. O., Castiglione, R., Salemi, M., Vicari, B. O., Mazzarino, M. C., & Vicari, E. (Accepted/In press). Effect of levofloxacin treatment on semen hyperviscosity in chronic bacterial prostatitis patients. Andrologia. https://doi.org/10.1111/and.12456

Effect of levofloxacin treatment on semen hyperviscosity in chronic bacterial prostatitis patients. / Vicari, L. O.; Castiglione, R.; Salemi, M.; Vicari, B. O.; Mazzarino, M. C.; Vicari, E.

In: Andrologia, 2015.

Research output: Contribution to journalArticle

Vicari, L. O. ; Castiglione, R. ; Salemi, M. ; Vicari, B. O. ; Mazzarino, M. C. ; Vicari, E. / Effect of levofloxacin treatment on semen hyperviscosity in chronic bacterial prostatitis patients. In: Andrologia. 2015.
@article{98b79c1a594449778ebc478e6c7550fe,
title = "Effect of levofloxacin treatment on semen hyperviscosity in chronic bacterial prostatitis patients",
abstract = "Changes in seminal fluid viscosity (SFV), reactive oxygen species (ROS) production, cytokines and seminal leucocyte concentration related to microbiological outcome in patients with chronic bacterial prostatitis (CBP) were studied. One hundred and ten infertile patients with CBP (positive sperm culture ≥105 colony-forming units [CFU] ml-1, pathogens or Chlamydia in expressed prostatic secretions) were treated with levofloxacin 500 mg daily for 14 consecutive days per month for 3 months. In case of bacterial prostatitis, two conditions were examined: responders, eradication of 0 to 3 CFU ml-1 (n = 78) and poor responders, >103 to 5 CFU ml-1 (n = 32). Compared with poor responders, responders showed a significant increase of sperm progressive motility and a significant decrease in seminal leucocyte count, SFV, liquefaction time, ROS production (in all fractions and conditions), seminal tumour necrosis factor-α and interleukin 6. None of these variables showed significant differences compared with a control group of 37 fertile men. On the other hand, the poor responders showed significant changes in these variables compared with matched pretreatment values. In patients with CBP, antibiotic therapy alone leads to eradication in ≈71{\%}, with improvement of sperm progressive motility, SFV and the framework of prooxidative factors. However, in the remaining ≈29{\%} with poor antibiotic responsiveness, a deterioration of all variables is observed.",
keywords = "Chronic bacterial prostatitis, Levofloxacin, Male infertility, Reactive oxygen species, Semen cytokines, Semen quantitative hyperviscosity",
author = "Vicari, {L. O.} and R. Castiglione and M. Salemi and Vicari, {B. O.} and Mazzarino, {M. C.} and E. Vicari",
year = "2015",
doi = "10.1111/and.12456",
language = "English",
journal = "Andrologia",
issn = "0303-4569",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Effect of levofloxacin treatment on semen hyperviscosity in chronic bacterial prostatitis patients

AU - Vicari, L. O.

AU - Castiglione, R.

AU - Salemi, M.

AU - Vicari, B. O.

AU - Mazzarino, M. C.

AU - Vicari, E.

PY - 2015

Y1 - 2015

N2 - Changes in seminal fluid viscosity (SFV), reactive oxygen species (ROS) production, cytokines and seminal leucocyte concentration related to microbiological outcome in patients with chronic bacterial prostatitis (CBP) were studied. One hundred and ten infertile patients with CBP (positive sperm culture ≥105 colony-forming units [CFU] ml-1, pathogens or Chlamydia in expressed prostatic secretions) were treated with levofloxacin 500 mg daily for 14 consecutive days per month for 3 months. In case of bacterial prostatitis, two conditions were examined: responders, eradication of 0 to 3 CFU ml-1 (n = 78) and poor responders, >103 to 5 CFU ml-1 (n = 32). Compared with poor responders, responders showed a significant increase of sperm progressive motility and a significant decrease in seminal leucocyte count, SFV, liquefaction time, ROS production (in all fractions and conditions), seminal tumour necrosis factor-α and interleukin 6. None of these variables showed significant differences compared with a control group of 37 fertile men. On the other hand, the poor responders showed significant changes in these variables compared with matched pretreatment values. In patients with CBP, antibiotic therapy alone leads to eradication in ≈71%, with improvement of sperm progressive motility, SFV and the framework of prooxidative factors. However, in the remaining ≈29% with poor antibiotic responsiveness, a deterioration of all variables is observed.

AB - Changes in seminal fluid viscosity (SFV), reactive oxygen species (ROS) production, cytokines and seminal leucocyte concentration related to microbiological outcome in patients with chronic bacterial prostatitis (CBP) were studied. One hundred and ten infertile patients with CBP (positive sperm culture ≥105 colony-forming units [CFU] ml-1, pathogens or Chlamydia in expressed prostatic secretions) were treated with levofloxacin 500 mg daily for 14 consecutive days per month for 3 months. In case of bacterial prostatitis, two conditions were examined: responders, eradication of 0 to 3 CFU ml-1 (n = 78) and poor responders, >103 to 5 CFU ml-1 (n = 32). Compared with poor responders, responders showed a significant increase of sperm progressive motility and a significant decrease in seminal leucocyte count, SFV, liquefaction time, ROS production (in all fractions and conditions), seminal tumour necrosis factor-α and interleukin 6. None of these variables showed significant differences compared with a control group of 37 fertile men. On the other hand, the poor responders showed significant changes in these variables compared with matched pretreatment values. In patients with CBP, antibiotic therapy alone leads to eradication in ≈71%, with improvement of sperm progressive motility, SFV and the framework of prooxidative factors. However, in the remaining ≈29% with poor antibiotic responsiveness, a deterioration of all variables is observed.

KW - Chronic bacterial prostatitis

KW - Levofloxacin

KW - Male infertility

KW - Reactive oxygen species

KW - Semen cytokines

KW - Semen quantitative hyperviscosity

UR - http://www.scopus.com/inward/record.url?scp=84939634323&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939634323&partnerID=8YFLogxK

U2 - 10.1111/and.12456

DO - 10.1111/and.12456

M3 - Article

AN - SCOPUS:84939634323

JO - Andrologia

JF - Andrologia

SN - 0303-4569

ER -